Katsuhiko Tsukamoto

Yamanashi, JP 
Yamanashi, JP 

Overview

Katsuhiko Tsukamoto practices practicing medicine in Yamanashi, Japan.

Their clinical expertise encompasses Phacomatosis Pigmentovascularis, Klippel-Trenaunay Syndrome, Olmsted Syndrome, and Hemangiopericytoma.

They are actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 3 clinical trials.

Locations

Yamanashi, Japan
Other Locations
Kofu, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3 Multicenter, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Adult Patients With Atopic Dermatitis
A Phase 3 Multicenter, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Adult Patients With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 03, 2024
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
Enrollment Status: Completed
Publish Date: March 30, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

9 Total Publications

Case of cutaneous myopericytoma in a child and a mini-review of cases with children and adolescents.
Case of cutaneous myopericytoma in a child and a mini-review of cases with children and adolescents.
Journal: International journal of dermatology
Published: July 25, 2022

Frequently Asked Questions about Katsuhiko Tsukamoto

Is Katsuhiko Tsukamoto a top-rated expert for Phacomatosis Pigmentovascularis?

MediFind is an objective health platform that identifies experts based on real-world data. Katsuhiko Tsukamoto is classified as an Experienced expert for Phacomatosis Pigmentovascularis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Katsuhiko Tsukamoto participate in research or clinical trials?

Yes. Katsuhiko Tsukamoto has published 9 articles and abstracts on conditions like Phacomatosis Pigmentovascularis. You can view a list of Katsuhiko Tsukamoto's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Tsukamoto's expertise for a condition
ConditionClose
        View All 13 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile